Last month the world's leading pharmaceutical company received simultaneous FDA approval for two new therapies. Yet neither drug was invented by the company. Both were originally developed by small biotechs.
Researchers at the University of Bonn in Germany have succeeded in finding a potentially low-cost source of a potent antiviral compound known to prevent replication of the HIV virus in vitro.
Scientists at the John Innes plant research centre in Norwich, UK have uncovered a gene that could form the basis of new crop varieties able to cope with changes in world climate brought about by global warming.
Scientists at the University of Manchester have invented an electronic nose that can monitor odours and methane at waste landfill and water treatment plants remotely.
Nanotechnology has the power to transform healthcare. But Europe will lose out to the United States unless it can mount a coherent approach to developing nanomedicine, says a new report.
There's nothing light about the scope and ambitions of the University of Manchester's new interdisciplinary Photon Science Institute. The £40 million institute aims to be world-class in pioneering light and laser technologies.
Dental implant company Neoss Ltd raised £5 million in its third funding round, enabling it to further develop the technology and expand its sales and marketing operations.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.